-Hormonal gene regulation requires synthesis of PAR and its degradation to ADPribose by PARG -ADP-ribose is converted to ATP in the cell nuclei by hormone-activated NUDIX5/NUDT5 -Blocking nuclear ATP formation precludes hormone-induced chromatin remodeling, gene regulation and cell proliferation Summary Key nuclear processes in eukaryotes including DNA replication or repair and gene regulation require extensive chromatin remodeling catalyzed by energy consuming enzymes. How the energetic demands of such processes are ensured in response to rapid stimuli remains unclear. We have analyzed this question in the context of the massive gene regulation changes induced by progestins in breast cancer cells and found that ATP is generated in the cell nucleus via the hydrolysis of poly-ADP-ribose to ADP-ribose. Nuclear ATP synthesis requires the combined enzymatic activities of PARP1, PARG and NUDIX5/NUDT5. Although initiated via mitochondrial derived ATP, the nuclear source of ATP is essential for hormone induced chromatin remodeling, gene regulation and cell proliferation and may also participate in DNA repair. This novel pathway reveals exciting avenues of research for drug development. 130 w PARP1 DNA damage Family Expression Acute Lymphobasltic Leukemia v Blood monoculcear cells I J
Graphical Summary
Breast Cancer Cell The nucleus of human cells requires an immense amount of energy to replicate or to repair the genome and to reprogram gene expression during differentiation or in response to external cues. Extensive changes in chromatin compaction and nucleosome organization are required to ensure gene accessibility for regulatory proteins and enzymes involved in these processes. First the chromatin fiber must be de-condensed followed by mobilization of the nucleosomes. Repositioning by sliding a single nucleosome core particle requires the breaking and reforming of hundreds of interactions between positively charged amino acids in histones and phosphates in the DNA backbone. A complete round of nucleosome remodeling in vitro requires the hydrolysis of ≈1000 ATP molecules by the ATPases/DNA-translocase domains that fuel the activity of dedicated ATP-dependent chromatin remodeling complexes 1 . In the nucleus of living cells the energy cost may be even higher, due to the added complexity imposed by the folding of the chromatin fiber, linker histones and other chromosomal proteins.
The general assumption is that nuclear energetic demands are met via the diffusion of ATP from the mitochondria. Although this may be the case in steady state situations, the question remains about the source of energy for extensive or sudden changes in chromatin. Nearly 60 years ago Allfrey and Mirsky proposed that ATP could be generated in isolated nuclei 2, 3 . It was suggested that the substrate for nuclear oxidative phosphorylation was in part generated by the ribose pathway 4 . In 1989 an enzyme activity named ADP-ribose pyrophosphorylase was postulated in HeLa cell nuclei that catalyzed the formation of ATP and Ribose-5-phosphate from ADP-ribose (ADPR) and PPi 5 . Moreover, ATP generation via ADPR catabolism has been shown to be involved in DNA repair and replication [8] [9] [10] . However, whether nuclear ATP is also required for changes in gene expression is not known.
We have previously shown that in response to progestins (Pg) breast cancer cells undergo extensive changes in gene expression that require a global modification of chromatin, mediated by kinases, histone modifying enzymes and ATP-dependent chromatin remodelers 9-12 . One key event in this response is the rapid and transient generation of poly-ADP-ribose (PAR) by PARP1 that consumes about 50% of the cellular NAD 13 . We considered the possibility that the transient nature of PAR accumulation reflects the need for the degradation of PAR that may play a role in the energetic balance of the cell nucleus.
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Nuclear ATP levels increase in response to progesterone
To measure ATP levels in living T47D M cells we utilized the ATeam constructs 14 , a set of FRET-based ATP/ADP detectors targeted to cell nucleus, mitochondria or cytosol (Extended Figure 1A) . ATP (YFP) /ADP (CFP) emissions were measured at 1 minute intervals after hormone stimulation, the images were processed and the ratio of ATP/ADP determined as described 15 (Extended Figure 1B) . The specificity and sensitivity of the ATeams were demonstrated using glucose stimulated Mito-ATeam in the presence or absence of the ATP-synthase inhibitor oligomycin. Levels of ATP increased rapidly (5-10 min) following the addition of glucose but the increase was inhibited by simultaneous treatment with oligomycin (Extended Figure 1C and D, respectively). Following addition of hormone to cells expressing the Nuclear-ATeam the nuclear ratio ATP (YFP) /ADP (CFP) increased rapidly to reached a low peak at 10-15 min followed by a much higher peak at 35-50 min, which was not found in solvent treated cells. Figure 1A shows snapshots at 5 min intervals of a representative cell expressing nuclear ATeam in response to hormone; Figure 1B shows quantification of 18 nuclei of cells incubated with hormone (left panel) or with solvent (right panel).
Quantification of cells expressing the mitochondrial-ATeam did not show the hormone-dependent increase in ATP ( Figure 1C ).
To confirm the FRET based results, we used nuclear, cytoplasmic and mitochondrial luciferase-based reporter constructs 16 to measure the levels of ATP by bioluminescence imaging (Extended Figure 1E and F). We confirmed the specific increase in nuclear ATP levels in cells treated with hormone, with a low peak at 10-15 min and a high peak at 40-50 minutes, which was not observed with the cytoplasmic or mitochondrial targeted constructs (Representative Bioluminescent image in Figure   1D and quantification in Figure 1E ).
The increase in nuclear ATP was compromised by inhibiting mitochondrial ATP production with oligomycin prior to hormone addition, indicating that mitochondrial ATP is required for initiation of nuclear ATP generation ( Figure 1F and G). In response to glucose the ATP levels in the nucleus increase rapidly ( Figure 1H left panel), likely via diffusion of ATP from the mitochondria, as demonstrated by its inhibition by oligomycin ( Figure 1H middle panel). The depletion of nuclear ATP in nuclei of cells treated with glucose and oligomycin demonstrates that the steady state nucleus contains a finite pool of ATP, which is depleted in around 10 min if it is not replenished (dashed line). However, in cells treated with hormone followed after 10 min by oligomycin, the nuclear levels of ATP continue to increase up to 40-50 min despite blocking of mitochondrial ATP production ( Figure 1H right panel). We conclude that nuclear ATP generated after 20 minutes of hormone treatment is independent of mitochondrial ATP synthesis.
PAR degradation to ADP-ribose is needed for nuclear ATP synthesis
Hormone induces a strong and transient increase in nuclear Poly-ADP-ribose (PAR) levels ( Figure 2A Figure 2C ). Both PAR and NAD levels return to basal state after 60-80 min of hormone ( Figure 2B and C). The recovery of NAD levels is dependent on PARG activity as shown with the selective inhibitor Tannic Acid, suggesting that ADPR is required ( Figure 2C ).
To test whether PAR and its degradation to ADPR were needed for nuclear ATP synthesis we measured nuclear ATP in the presence of inhibitors of PAPR1 or PARG.
We observed that specifically the high increase in nuclear ATP 40-50 min after hormone was dependent on PARP1 and PARG, while little changes were observed on mitochondrial or cytoplasmic ATP levels ( Figure 2D and 2E, and Extended Figure   2C ). These findings indicate that both the formation of PAR and its degradation to ADPR are needed for nuclear ATP generation.
Role of NUDIX5/NUDT5 in nuclear ATP synthesis
To gain further insight into the role of PAR, we performed proteomics analysis of the PAR interactome in untreated control cells (Time 0) and in cells treated with hormone for 30 minutes ( Figure 3A ). Cell extracts were immunoprecipitated with an antibody against PAR and precipitated proteins were analyzed by mass spectrometry. We identified 1091 unique either PARylated or PAR binding proteins (Extended Table 1) most of them following hormone induction, including histones, kinases, phosphatases and proteins involved in both NAD and nucleotide metabolism (Extended Table 2,   GO biological function analysis; Extended Tables 3 and 4) , which have also been reported in other cell types, including H2A, H1, XRCC5 and PARP1 itself 17 . Among the proteins involved in ADP and ADP-ribose metabolism we identified ARF3 (ADPribosylation factor 3), ADP-ribosylation factor-binding protein (GGA2) and ADPsugar pyrophosphatase NUDT5, also known as NUDIX5. Of them only NUDT5/NUDIX5 peptides were enriched following hormone treatment. Members of the Nudix (Nucleoside Diphosphate linked to X) superfamily of enzymes are found in all classes of organisms and catalyze the hydrolysis of a wide range of substrates including nucleotide sugars (review 18 ). NUDIX5 is in the top 10% of genes overexpressed in breast cancer in correlation with PARP1 and PARG (Extended Figure 3A ), a signature not shared by other members of the NUDIX family (Extended Figure 3B ). NUDIX5 overexpression correlates with known PARP1 interacting proteins in invasive breast carcinoma compared to normal breast (p=7.4E-30) in addition to other cancer types (Extended Figure 3C , D).
This evidence led us to hypothesize a crosstalk between PARP1, PARG and NUDIX5. Indeed NUDIX5 interacts with both PAR and PARG in a hormone dependent manner ( Figure 3B ). NUDIX5 has been reported to use ADP-ribose as substrate and to catalyze its hydrolysis to 5-ribose-phosphate and AMP 19 . Therefore we explored whether NUDIX5 was involved in nuclear ATP generation. When we knockdown NUDIX5 with a specific siRNA ( Figure 3C ), we observed no compensatory changes in gene expression of Nudix family members NUDT6, NUDT9 or NUDT12 (Extended Figure 3E ), but we found a marked reduction of the nuclear ATP peak at 30-50 min following hormone with no significant effect on mitochondrial ATP levels ( Figure 3D ). It is important to note that the peak of nuclear ATP around 10 min following hormone ( Figure 3D dash box) is independent of PAR formation or degradation, ( Figure 2E ) as well as of NUDIX5 ( Figure 3D ). We conclude that the early increase in ATP is mitochondria-dependent, while the later nuclear ATP peak at 30-50 min is mitochondria-independent but PARP, PARG and NUDIX dependent.
To directly test the enzymatic activity of NUDIX5, we synthesized recombinant human NUDIX5 in vitro (Extended Figure 3F ) and were able to detect the production of ATP in a luciferase assay when incubated at 37 o C in the presence of ADP-ribose, PPi and 4 mM Mg2 + ( Figure 3E , luciferase sensitivity using ATP standards Figure   3F ).
PAR derived ATP generation is needed for cell proliferation and chromatin remodeling
To explore the molecular processes for which PAR-derived ATP is used, we analyzed the effect of inhibiting nuclear ATP synthesis on chromatin dynamics and gene expression following hormone treatment. In expression microarray experiments, inhibition of PARG or depletion of NUDIX5 compromised regulation of 50% of hormone-responsive genes, with a significant overlap between genes dependent on PARG and on NUDIX5 ( Figure 4A ). 70% of both NUDIX5 and PARG dependent genes required both activities and majority of these genes also depended on PARylation ( Figure 4B and C). Consistent with previous reports 13, 20 , we found that genes dependent on PARP and PARG were enriched in processes such as signal transduction, cell proliferation, and stress (GO biological process analysis; Extended Table 5 and 6, Pathway enrichment analysis Extended Table 7 ). Progestin induced cell proliferation is abrogated by inhibition of PAR formation 13 , and we now found that both PARG and NUDIX5 are also required for progestin induced cell proliferation ( Figure 4D ). This effect was also observed with another breast cancer cell line MCF7 in response to oestrogen and the associated changes in gene expression were also dependent on PAR synthesis, degradation ADPR and NUDIX5
( Figure 4E and F, respectively; see also Extended Figure 4A ). In MCF7 cells estrogens induced increases in PAR and nuclear ATP that were dependent on the activities of PARP, PARG and NUDIX5 (Extended Figure 4B , and C). Although the response to estrogens of MCF7 cells was less synchronized, we conclude that nuclear ATP synthesis is required for the proliferative response of breast cancer cells to both steroid hormones.
In response to progestin there are rapid and global changes in chromatin, genome topology 11, 21 . Two consecutive chromatin remodeling events take place; an early one
(1-5 min) leading to histone H1 displacement that depends on the activities of CDK2, PARP1 and NURF, and a later one (2-60 min) leading to displacement of H2A/H2B dimers catalyzed by BAF and PCAF 11 . We confirm that the initial displacement of histone H1 depended on PARP1 activity, and found that it did not depend upon the actions of either PARG or NUDIX, while displacement at 30 and 60 min depended on all 3 activities ( Figure 4G In contrast the levels of RNA synthesis changes in response to hormone did not correlate significantly with nuclear ATP requirement (data not shown). This is consistent with a higher requirement for ADPR derived ATP at genes which regulation required extensive chromatin remodeling.
Discussion
Nuclear processes, including chromatin remodeling, transcription and replication require high amounts of energy in the form of ATP. Here we have described a novel mechanism of energy generation in the nuclei of breast cancer cells treated with hormone. In this model the high energetic cost of global chromatin modification is covered via the conversion of ADPR to ATP, to meet the local energy demands of the hormone response and to ensure cell survival.
Changes in nuclear ATP levels in response to hormone exhibit two distinct phases (Extended Figure 4D) ; an initial mitochondrial dependent phase (5-10 minutes)
followed by a later increase in ATP (30-50 minutes), which is independent of the mitochondria but dependent on nuclear ADPR (Figures 1). In the initial stages histone H1 and H2A/H2B are locally displaced from the promoters of hormone responsive genes via the concerted actions of PARP1 and the chromatin remodeling factors BPTF and BAF 11 . The energy requirements during these initial minutes are met via the pool of nuclear ATP present in the nucleus and are mitochondria dependent. It is possible that this ATP is also needed for the activity of the NMNAT-1 enzyme, which synthesizes NAD+ in the nucleus 22 . NMNAT-1 is known to interact with PARP1 and to co-localized on hormone responsive genes, and could provide the NAD substrate for activation and PAR synthesis by PARP1 23 . The activity of PARP1 during these initial stages is essential for the displacement of histone H1 13 and H2A/H2B, presumably via the traditional actions of PAR including direct parylation of histones 24 . PARP1 has been shown to be capable of replacing histone H1 in chromatin and could directly participate in H1 displacement 25 . During these initial stages of hormone activation the levels of PAR steadily increase in concert with a decrease in NAD levels.
During the second phase of hormone response and due to the direct action of PARG, PAR levels sharply decrease, accompanied by a rescue of NAD and an increase in nuclear ATP. This energy store is as a direct result of ADPR conversion to ATP via NUDIX5 and is essential for hormone dependent chromatin remodeling, gene regulation, cell proliferation and survival. In preliminary experiments we found that survival of MCF7 cells after DNA damage is dependent on PARP1, PARG and NUDIX5 (Data not shown).
Indeed we have preliminary evidence for a possible mechanism of NUDIX5 activation. Of all Nudix hydrolase family members only NUDIX5 is known to form a homodimer that hydrolyses ADPR to 5-ribose-phosphate and AMP 26 .
Phosphoproteomic analysis in T47D M identified NUDIX5 as phosphorylated threonine 45 (T45) prior to hormone and dephosphorylated following hormone treatment (Extended Figure 4E ). According to structural modelling T45 phosphorylation is essential for the stability of the homodimer and dephosphorylation of T45 should result in a de-stabilisation of the homodimer ( Figure   4I and J, Extended Figure 4F ). While hydrolysis of ADP-ribose to AMP would be energetically favorable with the homodimer, the reaction energetically and structurally feasible by the monomer in the presence of pyrophosphate would be the hydrolysis of ADP-ribose to 5-ribose phosphate and ATP. To test this hypothesis we generated NUDIX5 T45 phospho-null and phospho-mimetic mutants (T45A and T45D) and found that the T45D mutant behaves as dominant negative for Pg induced cell proliferation and gene regulation ( Figure 4G and H respectively). Moreover, recombinant wt NUDIX5 expressed in bacteria and likely unphosphorylated catalyzes the synthesis of ATP from ADP-ribose and PPi ( Figure 3E ).
Previous work suggested that ATP generated via ADPR might play a role in DNA damage and replication 7 . It has been suggested that in response to stimuli, and prior to transcription the torsional stress endured by the chromatin is relieved by the generation of local DNA breaks 27 . In addition an interaction of progesterone receptor with the DNA-dependent protein Kinase Ku has been reported 28 , further supporting a link between hormone action and DNA repair. It is therefore possible that the important role of parylation in DNA repair is also related to need of nuclear energy for the extensive chromatin remodeling associated with the repair process.
Finally NUDIX5 overexpression in breast cancer patients correlates with a poor outcome in hormone receptor positive breast cancer compared to PR and ER negative cancer (Extended Figure 4I ). This in addition to the observation that NUDIX5
overexpression is significant in multiple cancer types and correlates with high expression of PARP1 (Extended Figures 3D and 4J ) suggests that perhaps this mechanism of energy rescue and ATP generation is a process exploited in cancer and hence NUDIX5 provides an exciting new target for PARP1 combinatorial drug therapy.
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Materials and Methods

ATP in vitro Assay
